RPO LLC’s Humacyte Inc Warrant HUMAW Stock Holding History

RPO LLC’s Portfolio HUMAW Stock Details HUMAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-56,505	Closed	-$33.9K	–	90
2023 Q1	$33.9K	Sell	56,505 -200	-0.4%	-$119	0.01%	125
2022 Q4	$22.3K	Sell	56,705 -27,000	-32%	-$23.9K	0.01%	132
2022 Q3	$98K	Hold	83,705	–	–	0.02%	176
2022 Q2	$74K	Buy	83,705 +2,000	+2%	+$3.07K	0.02%	130
2022 Q1	$159K	Buy	+81,705	New	+$138K	0.05%	126

Other funds holding HUMAW

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

ETH

Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

RPO LLC's HUMAW Position: Q2 2023 in Review

RPO LLC sold out of Humacyte Inc Warrant (HUMAW) in Q2 2023, closing a stake of 56,505 shares — an estimated $33.9K sold.

RPO LLC first reported a position in HUMAW in Q1 2022 and held it in 5 quarters. The position peaked at $159K in Q1 2022. 8 funds tracked by Wall St. Rank hold HUMAW as of Q2 2023.

RPO LLC reported no remaining Humacyte Inc Warrant position as of Q2 2023 after selling out during the quarter.
RPO LLC sold 56,505 Humacyte Inc Warrant shares in Q2 2023, an estimated $33.9K.
RPO LLC first reported a position in Humacyte Inc Warrant in Q1 2022 and held it in 5 quarters.
RPO LLC's Humacyte Inc Warrant position peaked at $159K in Q1 2022.
8 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q2 2023.

Based on RPO LLC's 13F filing for Q2 2023, filed 9 Aug 2023.